cochrane innovations limited
cochrane innovations limited Company Information
Company Number
07674064
Next Accounts
Dec 2024
Industry
Other human health activities
Shareholders
the cochrane collaboration
Group Structure
View All
Contact
Registered Address
11-13 cavendish square, london, W1G 0AN
Website
www.cochrane.orgcochrane innovations limited Estimated Valuation
Pomanda estimates the enterprise value of COCHRANE INNOVATIONS LIMITED at £265.9k based on a Turnover of £248.4k and 1.07x industry multiple (adjusted for size and gross margin).
cochrane innovations limited Estimated Valuation
Pomanda estimates the enterprise value of COCHRANE INNOVATIONS LIMITED at £8.3m based on an EBITDA of £1m and a 8.18x industry multiple (adjusted for size and gross margin).
cochrane innovations limited Estimated Valuation
Pomanda estimates the enterprise value of COCHRANE INNOVATIONS LIMITED at £749k based on Net Assets of £304.8k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cochrane Innovations Limited Overview
Cochrane Innovations Limited is a dissolved company that was located in london, W1G 0AN with a Companies House number of 07674064. It operated in the other human health activities sector, SIC Code 86900. Founded in June 2011, it's largest shareholder was the cochrane collaboration with a 100% stake. The last turnover for Cochrane Innovations Limited was estimated at £248.4k.
Upgrade for unlimited company reports & a free credit check
Cochrane Innovations Limited Health Check
Pomanda's financial health check has awarded Cochrane Innovations Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £248.4k, make it smaller than the average company (£905.3k)
£248.4k - Cochrane Innovations Limited
£905.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (3.7%)
20% - Cochrane Innovations Limited
3.7% - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (32.1%)
100% - Cochrane Innovations Limited
32.1% - Industry AVG
Profitability
an operating margin of 410.7% make it more profitable than the average company (8%)
410.7% - Cochrane Innovations Limited
8% - Industry AVG
Employees
with 1 employees, this is below the industry average (21)
1 - Cochrane Innovations Limited
21 - Industry AVG
Pay Structure
on an average salary of £57.8k, the company has a higher pay structure (£23.6k)
£57.8k - Cochrane Innovations Limited
£23.6k - Industry AVG
Efficiency
resulting in sales per employee of £248.4k, this is more efficient (£44.8k)
£248.4k - Cochrane Innovations Limited
£44.8k - Industry AVG
Debtor Days
it gets paid by customers after 13 days, this is earlier than average (21 days)
13 days - Cochrane Innovations Limited
21 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cochrane Innovations Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cochrane Innovations Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 205 weeks, this is more cash available to meet short term requirements (111 weeks)
205 weeks - Cochrane Innovations Limited
111 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24.7%, this is a similar level of debt than the average (26.5%)
24.7% - Cochrane Innovations Limited
26.5% - Industry AVG
COCHRANE INNOVATIONS LIMITED financials
Cochrane Innovations Limited's latest turnover from December 2021 is £248.4 thousand and the company has net assets of £304.8 thousand. According to their latest financial statements, Cochrane Innovations Limited has 1 employee and maintains cash reserves of £394.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 248,360 | 323,807 | 248,564 | 142,605 | 161,102 | 75,608 | 320,570 | 49,933 | 67,014 | 63,836 | 75,750 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Gross Profit | 248,360 | 323,807 | 248,564 | 142,605 | 161,102 | 75,608 | 320,570 | ||||
| Admin Expenses | |||||||||||
| Operating Profit | -92,893 | -77,921 | -52,509 | 642 | |||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 245 | 138 | 74 | 0 |
| Pre-Tax Profit | 826,857 | 210,627 | 112,822 | -28,932 | -272,681 | -331,629 | 9,920 | -92,648 | -77,783 | -52,435 | 642 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 826,857 | 210,627 | 112,822 | -28,932 | -272,681 | -331,629 | 9,920 | -92,648 | -77,783 | -52,435 | 642 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 826,857 | 210,627 | 112,822 | -28,932 | -272,681 | -331,629 | 9,920 | -92,648 | -77,783 | -52,435 | 642 |
| Employee Costs | 57,788 | 64,988 | 62,129 | 60,430 | 203,567 | 217,306 | 170,730 | ||||
| Number Of Employees | 1 | 1 | 1 | 1 | 3 | 3 | 3 | ||||
| EBITDA* | -92,627 | -77,733 | -52,321 | 751 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 266 | 454 | 642 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 266 | 454 | 642 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 8,960 | 16,221 | 12,739 | 68,699 | 65,666 | 5,506 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 104,560 | 0 | 0 | 0 | 214 |
| Misc Debtors | 1,343 | 6,611 | 3,120 | 13,927 | 7,780 | 442 | 0 | 0 | 0 | 13 | 81,880 |
| Cash | 394,487 | 189,098 | 48,261 | 69,117 | 25,477 | 28,273 | 61,141 | 262,101 | 267,362 | 339,414 | 113,830 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 404,790 | 211,930 | 64,120 | 151,743 | 98,923 | 34,221 | 165,701 | 262,101 | 267,362 | 339,427 | 195,924 |
| total assets | 404,790 | 211,930 | 64,120 | 151,743 | 98,923 | 34,221 | 165,701 | 262,101 | 267,628 | 339,881 | 196,566 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 588 | 0 | 0 | 0 | 13,851 | 11,050 | 0 | 0 | 0 | 369 | 0 |
| Group/Directors Accounts | 83,539 | 7,336 | 15,266 | 223,039 | 216,836 | 249,552 | 32,222 | 179,258 | 16,510 | 39,251 | 45,593 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 15,814 | 57,528 | 112,415 | 61,009 | 15,687 | 17,364 | 45,685 | 4,969 | 80,594 | 51,954 | 231 |
| total current liabilities | 99,941 | 64,864 | 127,681 | 328,126 | 246,374 | 277,966 | 77,907 | 184,227 | 97,104 | 91,574 | 45,824 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 99,941 | 64,864 | 127,681 | 328,126 | 246,374 | 277,966 | 77,907 | 184,227 | 97,104 | 91,574 | 45,824 |
| net assets | 304,849 | 147,066 | -63,561 | -176,383 | -147,451 | -243,745 | 87,794 | 77,874 | 170,524 | 248,307 | 150,742 |
| total shareholders funds | 304,849 | 147,066 | -63,561 | -176,383 | -147,451 | -243,745 | 87,794 | 77,874 | 170,524 | 248,307 | 150,742 |
| Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | -92,893 | -77,921 | -52,509 | 642 | |||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 266 | 188 | 188 | 109 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -12,529 | 6,973 | -66,767 | 9,180 | 67,498 | -98,612 | 104,560 | -13 | -13 | -82,081 | 82,094 |
| Creditors | 588 | 0 | 0 | -13,851 | 2,801 | 11,050 | 0 | -369 | -369 | 369 | 0 |
| Accruals and Deferred Income | -41,714 | -54,887 | 51,406 | 45,322 | -1,677 | -28,321 | 40,716 | -46,985 | 28,640 | 51,723 | 231 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -139,968 | -49,449 | 81,852 | -81,112 | |||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 76,203 | -7,930 | -207,773 | 6,203 | -32,716 | 217,330 | -147,036 | 140,007 | -22,741 | -6,342 | 45,593 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 245 | 138 | 74 | 0 |
| cash flow from financing | -592,871 | -7,930 | -207,773 | 6,203 | 336,259 | 217,420 | -147,036 | 62,467 | -22,603 | 143,732 | 195,693 |
| cash and cash equivalents | |||||||||||
| cash | 205,389 | 140,837 | -20,856 | 43,640 | -2,796 | -32,868 | -200,960 | -77,313 | -72,052 | 225,584 | 113,830 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 205,389 | 140,837 | -20,856 | 43,640 | -2,796 | -32,868 | -200,960 | -77,313 | -72,052 | 225,584 | 113,830 |
cochrane innovations limited Credit Report and Business Information
Cochrane Innovations Limited Competitor Analysis
Perform a competitor analysis for cochrane innovations limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other undefined companies, companies in W1G area or any other competitors across 12 key performance metrics.
cochrane innovations limited Ownership
COCHRANE INNOVATIONS LIMITED group structure
Cochrane Innovations Limited has no subsidiary companies.
Ultimate parent company
1 parent
COCHRANE INNOVATIONS LIMITED
07674064
cochrane innovations limited directors
Cochrane Innovations Limited currently has 6 directors. The longest serving directors include Professor Lorne Becker (Jun 2011) and Mr Marc Pelletier (Jul 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor Lorne Becker | Usa | 79 years | Jun 2011 | - | Director |
| Mr Marc Pelletier | England | 67 years | Jul 2016 | - | Director |
| Ms Uchenna Izundu | England | 46 years | Jul 2016 | - | Director |
| Mr Jordi Pardo | England | 50 years | Sep 2019 | - | Director |
| Mr Jordi Pardo | England | 50 years | Sep 2019 | - | Director |
| Mrs Catherine Spencer | England | 50 years | Jul 2022 | - | Director |
P&L
December 2021turnover
248.4k
-23%
operating profit
1m
0%
gross margin
100%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2021net assets
304.8k
+1.07%
total assets
404.8k
+0.91%
cash
394.5k
+1.09%
net assets
Total assets minus all liabilities
cochrane innovations limited company details
company number
07674064
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 2011
age
13
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2021
previous names
N/A
accountant
-
auditor
SAYER VINCENT LLP
address
11-13 cavendish square, london, W1G 0AN
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
cochrane innovations limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cochrane innovations limited.
cochrane innovations limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for COCHRANE INNOVATIONS LIMITED. This can take several minutes, an email will notify you when this has completed.
cochrane innovations limited Companies House Filings - See Documents
| date | description | view/download |
|---|
